Home  |  Contact

Cellosaurus NS0 (CVCL_3940)

[Text version]

Cell line name NS0
Synonyms NSO; NS/0; NS/O
Accession CVCL_3940
Resource Identification Initiative To cite this cell line use: NS0 (RRID:CVCL_3940)
Comments Group: Hybridoma fusion partner cell line.
Characteristics: Commonly employed for monoclonal antibody expression.
Characteristics: Lacks endogenous glutamine synthetase (GS) activity.
Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
Disease Mouse plasma cell myeloma (NCIt: C125417)
Species of origin Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Breed/subspecies: BALB/c.
Hierarchy Parent: CVCL_2155 (P3/NS1/1-Ag4.1)
CVCL_6494 (022HU-NSO)CVCL_A0HG (10E4)CVCL_LC04 (11BD-2E11-2)
CVCL_A0HH (16A3)CVCL_DN54 (17G1)CVCL_A0HV (1A-3187)
CVCL_A0HW (1A-4246)CVCL_LC05 (1A245.6)CVCL_A0HX (1B-3246)
CVCL_A0HY (1B-3440)CVCL_A0HZ (1B-4863)CVCL_A0IA (1B-4971)
CVCL_A0HI (1B5)CVCL_CZ91 (1CB4)CVCL_A0HJ (1D2 [Mouse hybridoma against human RPSA])
CVCL_A0CA (1G10 [Mouse hybridoma against HIV-1 rev])CVCL_A0CB (1G7)CVCL_J659 (2-179-E11)
CVCL_9149 (20C2)CVCL_A0HK (21H1)CVCL_A0HL (2H9 [Mouse hybridoma against human RPSA])
CVCL_J666 (357-101-4)CVCL_J667 (357-167-24)CVCL_J668 (359-238-8)
CVCL_J669 (359-81-11)CVCL_A0HM (3E6 [Mouse hybridoma against human RPSA])CVCL_A0HN (3G5 [Mouse hybridoma against human RPSA])
CVCL_2H34 (3NB12.13)CVCL_G693 (41-2)CVCL_A0HP (4C11 [Mouse hybridoma against human RPSA])
CVCL_A0HQ (4F6 [Mouse hybridoma against human RPSA])CVCL_G694 (50-6)CVCL_J061 (53B3)
CVCL_J062 (54B3)CVCL_XI16 (6/22-10-30-13)CVCL_A0HR (7A5)
CVCL_G696 (7E12H12)CVCL_A0HS (8E4 [Mouse hybridoma against human RPSA])CVCL_A0CC (8E7 [Mouse hybridoma against HIV-1 rev])
CVCL_A0HU (9D8)CVCL_A0CD (9G2 [Mouse hybridoma against HIV-1 rev])CVCL_L815 (AFRC 17D1)
CVCL_K191 (AFRC MAC 156)CVCL_K192 (AFRC MAC 157)CVCL_K193 (AFRC MAC 158)
CVCL_K194 (AFRC MAC 159)CVCL_K195 (AFRC MAC 160)CVCL_L827 (AFRC MAC 260)
CVCL_LB97 (AR40A603.13)CVCL_LH69 (AR47A6.4.2)CVCL_LH70 (AR52A301.5)
CVCL_LB98 (AR53A10.11)CVCL_LB99 (AR58A258.8)CVCL_LC00 (AR58A314.1)
CVCL_1954 (BA-D5)CVCL_1955 (BA-F8)CVCL_G695 (BA-G5)
CVCL_1960 (BF-32)CVCL_1961 (BF-34)CVCL_1962 (BF-45)
CVCL_KA95 (BF-B6)CVCL_1963 (BF-F3)CVCL_G162 (BMAC-1)
CVCL_A6QK (CK-JIL)CVCL_VK51 (CT-1 [Mouse hybridoma against human TNF])CVCL_G692 (DII 33.1)
CVCL_DF71 (HB 34-1)CVCL_A5YP (HET-37)CVCL_A9EN (HRP 16-1)
CVCL_A3CK (KT65)CVCL_L704 (LDS 73/LW1)CVCL_UW14 (Luc63.2.22)
CVCL_UW15 (Luc90)CVCL_J222 (MH01)CVCL_K161 (NI 1 alpha 364/3B3-14)
CVCL_K162 (NI 1 alpha 364/8C4-8)CVCL_J845 (NI 3 416/6C6-6)CVCL_J846 (NI 3 416/7B5-5)
CVCL_J847 (NI 4 426/1A6-10)CVCL_J848 (NI 4 426/7A3-3)CVCL_J849 (NI 4 426/8B1-7)
CVCL_J850 (NI G 386/3B6-12)CVCL_J851 (NI G 386/3D1-16)CVCL_J852 (NI GM 465/7A6-37)
CVCL_J853 (NORIg 7.16.2)CVCL_G345 (NS0-SFM)CVCL_G346 (NS0-Turbodoma)
CVCL_DD16 (NS0bcl-2)CVCL_U023 (OX-23)CVCL_U024 (OX-24)
CVCL_J181 (OX-26)CVCL_J183 (OX-29)CVCL_J185 (OX-30)
CVCL_J186 (OX-33)CVCL_J187 (OX-34)CVCL_J188 (OX-35 clone 5)
CVCL_J189 (OX-36 clone 3)CVCL_J191 (OX-39)CVCL_J193 (OX-41)
CVCL_J194 (OX-42)CVCL_J195 (OX-43)CVCL_J196 (OX-44)
CVCL_J197 (OX-45)CVCL_U025 (OX-46)CVCL_J198 (OX-47)
CVCL_X512 (OX-48)CVCL_J199 (OX-49)CVCL_J200 (OX-50)
CVCL_J201 (OX-52)CVCL_J202 (OX-53)CVCL_J203 (OX-54)
CVCL_J204 (OX-55)CVCL_J209 (OX-60)CVCL_J210 (OX-61)
CVCL_J211 (OX-62)CVCL_J212 (OX-68)CVCL_2183 (RV-C2)
CVCL_2184 (SC-71)CVCL_2185 (SC-75)CVCL_2216 (TI-1 [Mouse hybridoma])
CVCL_2217 (TI-4)CVCL_KA81 (VPM 1)CVCL_KA82 (VPM 14)
CVCL_KA83 (VPM 15)CVCL_KA84 (VPM 16)CVCL_KA85 (VPM 17)
CVCL_G164 (VPM 18)CVCL_G165 (VPM 19)CVCL_KA89 (VPM 29)
CVCL_KA86 (VPM 3)CVCL_KR64 (VPM 30)CVCL_G166 (VPM 36)
CVCL_G167 (VPM 37)CVCL_G168 (VPM 38)CVCL_KA87 (VPM 39)
CVCL_KA88 (VPM 4)CVCL_G169 (VPM 40)CVCL_G170 (VPM 41)
CVCL_G171 (VPM 43)CVCL_G172 (VPM 44)CVCL_G173 (VPM 45)
CVCL_G174 (VPM 46)CVCL_G175 (VPM 47)CVCL_G176 (VPM 48)
CVCL_G177 (VPM 5)CVCL_G178 (VPM 54)CVCL_G179 (VPM 6)
CVCL_G180 (VPM 8)
Sex of cell Female
Category Cancer cell line
Web pages https://en.wikipedia.org/wiki/NS0_cell

PubMed=19003032; DOI=10.1007/s10616-005-3563-z
Zhang J., Robinson D.
Development of animal-free, protein-free and chemically-defined media for NS0 cell culture.
Cytotechnology 48:59-74(2005)

PubMed=18617141; DOI=10.1016/j.jprot.2008.02.003
de la Luz-Hernandez K.R., Rojas-del Calvo L., Rabasa-Legon Y., Lage-Castellanos A., Castillo-Vitlloch A., Diaz J., Gaskell S.
Metabolic and proteomic study of NS0 myeloma cell line following the adaptation to protein-free medium.
J. Proteomics 71:133-147(2008)

Cell line collections ECACC; 85110503
NCBI_Iran; C142
RCB; RCB0213
TKG; TKG 0594
Cell line databases/resources CLO; CLO_0008203
CLO; CLO_0008206
CLO; CLO_0050179
CLDB; cl3737
CLDB; cl3738
CLDB; cl3739
FCS-free; 110-17-508-1-16-3
Lonza; 757
Anatomy/cell type resources BTO; BTO:0004968
Chemistry resources ChEMBL-Cells; CHEMBL3307752
ChEMBL-Targets; CHEMBL615003
Encyclopedic resources Wikidata; Q20164415
Entry history
Entry creation04-Apr-2012
Last entry update02-Jul-2020
Version number14